About Our Company
Pharmos, as well as the other twinning Pharmos Corp projects and its biopharmaceutical subdivisions, has been cultivating and actively supporting trailblazing clinical and paramedical projects for more than 20 years. We are a young branch ready for healthy competitiveness in the market of medical needs. Our philanthropic activities are reflected in the efficient clinical testings and promotion of tenable therapeutics.
Pharmos is not the largest but efficient biotech company, with differentiated oncology medicines, immunology and ophthalmology solutions, infectious diseases meds, and treatments for central nervous system conditions. Cancer diagnostics and diabetes management are among our strongest sides.
Founded more than 21 years ago, Pharmos Corp and its branches keep on searching for strengthened ways of prevention, preliminary treatment, management, and healing products to establish a sustainable social contribution. We strongly believe that every patient deserves to have full access to the most modern innovative pharmaceutical products.
Our stakeholders are relevant and trustworthy. More than 30 pharmaceutical items and medication therapies submitted by Pharmos Corp technicians and knowledgeable medical practitioners are found in the World Health Organization Model Lists of Essential Medicines.
Among the most sought-after meds we offer are:
- Life-saving antibiotics, helping to treat bacterial infections.
- Antimalarials, preventing malaria risks for the travelers.
- Cancer medicines, including hormone therapy, targeted therapies, immunotherapies, and maintenance medications.
One of the most popular drugs we sell daily is Lisinopril (which is a generic name). The med is also known as Prinivil and Zestril. It’s a blood pressure med aimed to prevent kidney conditions, heart strokes, and severe heart attacks. Lisinopril lowers blood pressure, relaxing the blood vessels and treating heart failure. It’s an ACE inhibitor directed by your doctor.
Our SDGs (Sustainable Development Goals) include:
- Good health and well-being;
- Industry, innovation, and infrastructure;
- Responsible consumption and production;
- Climate action;
- Reducing inequality;
- Partnerships for the goals.
Pharmos Corp make up one of the Group Leaders in sustainable contributions within the Life Sciences, Biotechnology, and Pharmaceuticals.
We endeavor to avoid the issues concerning the violation of human rights, demonstrating personal accountability for the behavior of our management, subdivisions, and counterparts. We are committed to managing any risks in our pharma supply chain. We’ve been making progress in this virtue for many years, and we’re not going to ignore it.
Human rights violation risks are elevated and Third-Party Risk Management is one of our core practices. We optimize the MPC supply chain through Human Rights & Third-Party Risk Management policy.
Our ultimate goal is to promote and deliver efficacious and safe medications, helping the patients and customers develop a healthier and more productive way of living. We confer a distinction on our best shareholders and contribute to the research and development of the most secure generations of pharmaceutical goods.